Oncogenesis : Impact Factor & More
eISSN: 2157-9024pISSN: 2157-9024
Open AccessShare this on:
Key Metrics
CiteScore 
11.4
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Cancer Research
SNIP
1.45
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Oncogenesis
Oncogenesis Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 3190 | USD 3890 | GBP 2690 |
| Publication Time | 26 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Oncogenesis ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Oncogenesis
SREBP2 regulates CCDC25 expression and promotes tumor metastasis in Triple-Negative Breast Cancer.
- 13 Apr 2026
- Oncogenesis
Correction: Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma.
- 10 Apr 2026
- Oncogenesis
Choroid plexus carcinoma: state of the field and emerging directions.
- 6 Apr 2026
- Oncogenesis
GPX3 suppresses gallbladder cancer progression by modulating redox balance, glycolysis, and anti-tumor immunity.
- 2 Apr 2026
- Oncogenesis
The oncogenic control of nucleotide synthesis.
- 26 Mar 2026
- Oncogenesis
Teriflunomide modulates the PD-1/PD-L1 axis and enhances antitumor immunity in colorectal cancer.
- 18 Mar 2026
- Oncogenesis
SREBP2 regulates CCDC25 expression and promotes tumor metastasis in Triple-Negative Breast Cancer.
- 13 Apr 2026
- Oncogenesis
Correction: Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma.
- 10 Apr 2026
- Oncogenesis
Choroid plexus carcinoma: state of the field and emerging directions.
- 6 Apr 2026
- Oncogenesis
GPX3 suppresses gallbladder cancer progression by modulating redox balance, glycolysis, and anti-tumor immunity.
- 2 Apr 2026
- Oncogenesis
The oncogenic control of nucleotide synthesis.
- 26 Mar 2026
- Oncogenesis
Teriflunomide modulates the PD-1/PD-L1 axis and enhances antitumor immunity in colorectal cancer.
- 18 Mar 2026
- Oncogenesis
FAQs on Oncogenesis
How long has Oncogenesis been actively publishing? 
What is the publishing frequency of Oncogenesis?
How many articles did Oncogenesis publish last year?
What is the eISSN & pISSN for Oncogenesis?
What is Citescore for Oncogenesis?
What is SNIP score for Oncogenesis?
What is the SJR for Oncogenesis?
Who is the publisher of Oncogenesis?
